checkAd
    Startseite > Aktien > Agenus > Nachrichten
    Agenus Aktie
    15,690
     
    USD
    +3,84 %
    +0,580 USD
    Letzter Kurs 02:00:00 Nasdaq
    15,650
     
    USD
    400 STK
    Geldkurs 31.05.24
    15,680
     
    USD
    300 STK
    Briefkurs 31.05.24
    ISIN: US00847G8042 · WKN: A403RK · SYM: AGEN · USA

    Neueste Nachrichten

    Agenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    24.05.24 · Business Wire (engl.) · Agenus
    Breakthrough Data on Botensilimab/Balstilimab in MSS CRC Presented at the 2024 ASCO Annual Meeting
    23.05.24 · Business Wire (engl.) · Agenus
    Agenus to Participate in Goldman Sachs 45th Annual Global Healthcare Conference
    23.05.24 · Business Wire (engl.) · Agenus
    FDA Grants Agenus Type B End-of-Phase 2 Meeting to Discuss BOT/BAL Therapy for Relapsed or Refractory Metastatic Colorectal Cancer
    16.05.24 · Business Wire (engl.) · Agenus
    Agenus Reports First Quarter 2024 Results
    07.05.24 · Business Wire (engl.) · Agenus
    Ligand and Agenus Enter Into $100 Million Royalty Financing Agreement
    07.05.24 · Business Wire (engl.) · Ligand Pharmaceuticals
    Agenus Regains Compliance with Nasdaq Minimum Bid Price Requirement
    01.05.24 · Business Wire (engl.) · Agenus
    Botensilimab/Balstilimab Data in MSS CRC Selected for the American Society of Clinical Oncology 2024 Annual Meeting
    24.04.24 · Business Wire (engl.) · Agenus
    Agenus to Provide First Quarter 2024 Financial Report and Corporate Update
    23.04.24 · Business Wire (engl.) · Agenus
    Agenus Announces Updated Phase 1 Data and Progress on BOT/BAL Development in Metastatic MSS Colorectal Cancer
    12.04.24 · Business Wire (engl.) · Agenus
    Agenus Announces Reverse Stock Split of Common Stock
    05.04.24 · Business Wire (engl.) · Agenus
    Agenus Reports Fourth Quarter and Full Year 2023 Results
    14.03.24 · Business Wire (engl.) · Agenus